IP Library Granted Patent US 12,558,688
Granted Patent B2
US 12,558,688 · App. 17/072,332 · Granted Feb 24, 2026

Microfluidic device and method

Inventors: Erik Mikael Olsson (Uppsala, SE); Austin Derfus (Solana Beach, CA); Armando Tovar (San Diego, CA); Justin Davidson (San Diego, CA); Tuan Do (San Diego, CA); Paul Crivelli (San Diego, CA); Matthew Wang (San Diego, CA)
Assignee: Ortho-Clinical Diagnostics, Inc.
B01L3/502746B01L3/502723G01N33/491G01N33/54306G01N33/6887B01L2200/16B01L2300/0681B01L2300/0816B01L2300/0867B01L2300/0883B01L2400/0406B01L2400/0487B01L2400/0688B01L2400/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,558,688
App. No.
17/072,332
Granted
Feb 24, 2026
Kind
B2
Abstract

A combination of components in a capillary flow channel uses capillary forces to passively control the movement of liquid samples within a microfluidic device. To detect a target, a liquid sample introduced to a proximal portion of capillary channel of a microfluidic device moves by capillary action along the specific components of capillary channel.

Claims (36)

1 . A microfluidic device comprising:

a port configured to receive a liquid sample, a filter pocket, a mixing well, and a capillary flow channel;

wherein the capillary flow channel comprises a proximal opening, a distal opening, a dry reagent zone, a pinch region, and a detection zone;

wherein the filter pocket comprises a filter and disposed substantially at the proximal opening;

wherein the mixing well comprises a length, a width, a height, and a perimeter, the width decreasing from a central portion of the mixing well toward the perimeter along at least two opposed directions, wherein the mixing well is disposed distal to the filter pocket;

wherein the dry reagent zone containing a reagent, the dry reagent zone disposed distal to the mixing well;

wherein the pinch region is configured to redirect flow,

wherein the pinch region is disposed distal to the dry reagent zone and has a width that is less than that of the capillary flow channel;

wherein the pinch region has a width that is at most half the width of the capillary flow channel;

wherein the detection zone is disposed distal to a fluid resistance feature,

wherein the distal opening is tapered to control a flow rate, and wherein the filter pocket, the mixing well, the dry reagent zone, pinch region, and the detection zone are in fluidic communication.

2 . The microfluidic device of claim 1 , wherein the filter pocket comprises a sample inlet having a recess configured to receive a liquid sample, a filter landing, and a vent configured to permit air to be displaced upon receiving the liquid sample.

3 . The microfluidic device of claim 2 , wherein the filter landing includes a raised plateau extending from a distal edge of the filter pocket.

4 . The microfluidic device of claim 2 , wherein the filter pocket further comprises a catwalk strip disposed for directing a fluid deposited at the sample inlet to the filter landing.

5 . The microfluidic device of claim 1 , wherein the mixing well is dimensioned to move a filtered liquid sample by capillary action.

6 . The microfluidic device of claim 1 , wherein the dry reagent zone contains walls with a hydrophobic ink.

7 . The microfluidic device of claim 1 , wherein the pinch region is configured with a lobe, optionally wherein the pinch region comprises a portion of the capillary flow channel that is lobed in a direction that is substantially perpendicular to a length of the microfluidic device.

8 . The microfluidic device of claim 1 , wherein the detection zone contains at least one solid phase capture spot configured to bind a specific analyte.

9 . The microfluidic device of claim 1 , further comprising two or more solid phase capture spots arranged in a series along a length of the detection zone.

10 . The microfluidic device of claim 8 , wherein the at least one solid phase capture spot provides a signal measured by a reader.

11 . The microfluidic device of claim 1 , further comprising a waste channel distal to the detection zone.

12 . The microfluidic device of claim 11 , wherein a portion of a substrate covers the waste channel and that portion is printed with hydrophobic ink that increases flow rate and decreases wash time.

13 . The microfluidic device of claim 1 , wherein the capillary flow channel is disposed between an upper substrate and a lower substrate.

14 . The microfluidic device of claim 13 , wherein the lower substrate comprises a first portion having a first depth and a second portion having a second depth that is less than the first depth.

15 . The microfluidic device of claim 14 , wherein a portion having a first depth is convex and a portion having a second depth is planar.

16 . The microfluidic device of claim 1 , wherein the filter pocket is configured to move liquid by capillary action along the capillary flow channel and into the mixing well of the capillary flow channel.

17 . The microfluidic device of claim 7 , wherein the mixing well is configured to move liquid by capillary action along the capillary flow channel and into the pinch region of the capillary flow channel.

18 . The microfluidic device of claim 1 , wherein the mixing well comprises a depth that is greater than a depth of the capillary flow channel.

19 . A method for determining a presence or an absence of a cardiac troponin in a patient sample, comprising:

placing a blood sample on a microfluidic device of claim 1 to label the cardiac troponin, if present in the patient sample, with a label comprising a binding partner for the cardiac troponin and a detectable moiety; and

detecting a presence of cardiac troponin in the patient sample by determining a presence or an absence of the label,

wherein detection of the presence of the label indicates the presence of cardiac troponin in the patient sample, wherein an assay has a limit of quantitation of about 3 μg/mL with a coefficient of variation of less than about 20%.

20 . The method of claim 19 , wherein the cardiac troponin is cardiac troponin I (cTnI).

21 . The method of claim 19 , wherein the cardiac troponin is cardiac troponin T (cTnT).

22 . The method of claim 19 , wherein the cardiac troponin is a complex of cTnI and cTnT.

23 . The microfluidic device of claim 1 , wherein the mixing well is substantially bowl-shaped.

Assignments (4)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2020
From: OLSSON, ERIK MIKAEL; DERFUS, AUSTIN; TOVAR, ARMANDO; DAVIDSON, JUSTIN; DO, TUAN; CRIVELLI, PAUL; WANG, MATTHEW
To: QUIDEL CARDIOVASCULAR INC.
Reel/Frame 054154/0402 →